Ulimorelin HydrochlorideProduct ingredient for Ulimorelin
- Name
- Ulimorelin Hydrochloride
- Drug Entry
- Ulimorelin
Ulimorelin is a novel small molecule ghrelin agonist being developed by Tranzyme Pharma as a first-in-class treatment for both POI and diabetic gastroparesis, serious medical conditions in which motility of the GI tract is severely impaired.
- Accession Number
- DBSALT002140
- Structure
Structure for Ulimorelin Hydrochloride (DBSALT002140)
- Synonyms
- Not Available
- External IDs
- TZP-101